233 related articles for article (PubMed ID: 18423453)
21. Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant.
Gaffield ME; Curtis KM; Mohllajee AP; Peterson HB
Contraception; 2006 Feb; 73(2):134-44. PubMed ID: 16413844
[TBL] [Abstract][Full Text] [Related]
22. [Insertion problems, removal problems, and contraception failures with Implanon].
Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F; Llabres S; Autret-Leca E;
Gynecol Obstet Fertil; 2005 Dec; 33(12):986-90. PubMed ID: 16321557
[TBL] [Abstract][Full Text] [Related]
23. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants.
Taneepanichskul S; Reinprayoon D; Thaithumyanon P; Praisuwanna P; Tosukhowong P; Dieben T
Contraception; 2006 Apr; 73(4):368-71. PubMed ID: 16531169
[TBL] [Abstract][Full Text] [Related]
24. Contraceptive efficacy and side effects of Implanon.
Gezginc K; Balci O; Karatayli R; Colakoglu MC
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):362-5. PubMed ID: 17853166
[TBL] [Abstract][Full Text] [Related]
25. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
Biswas A; Biswas S; Viegas OA
Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
[TBL] [Abstract][Full Text] [Related]
26. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.
Bennink HJ
Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():12-20. PubMed ID: 11246602
[TBL] [Abstract][Full Text] [Related]
27. A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China.
Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):85-93. PubMed ID: 10427483
[TBL] [Abstract][Full Text] [Related]
28. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.
Brito MB; Ferriani RA; Meijers JC; Garcia AA; Quintana SM; Silva de Sá MF; Vieira CS
Thromb Res; 2012 Sep; 130(3):355-60. PubMed ID: 22542366
[TBL] [Abstract][Full Text] [Related]
29. Neuropathy associated with etonogestrel implant insertion.
Brown M; Britton J
Contraception; 2012 Nov; 86(5):591-3. PubMed ID: 22770789
[TBL] [Abstract][Full Text] [Related]
30. Implant contraception.
Meckstroth KR; Darney PD
Semin Reprod Med; 2001 Dec; 19(4):339-54. PubMed ID: 11727176
[TBL] [Abstract][Full Text] [Related]
31. A clinical evaluation of bleeding patterns, adverse effects, and satisfaction with the subdermal etonogestrel implant among postpartum and non-postpartum users.
Wahab NA; Rahman NA; Mustafa KB; Awang M; Sidek AA; Ros RM
Int J Gynaecol Obstet; 2016 Feb; 132(2):237-8. PubMed ID: 26617248
[No Abstract] [Full Text] [Related]
32. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group.
Croxatto HB; Urbancsek J; Massai R; Coelingh Bennink H; van Beek A
Hum Reprod; 1999 Apr; 14(4):976-81. PubMed ID: 10221230
[TBL] [Abstract][Full Text] [Related]
33. Etonogestrel implant in adolescents: evaluation of clinical aspects.
Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
Contraception; 2011 Apr; 83(4):336-9. PubMed ID: 21397091
[TBL] [Abstract][Full Text] [Related]
34. [Vaginal contraception: new form of administration of hormonal contraception].
Knuist M; Hamerlynck JV
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2095-7. PubMed ID: 14619196
[TBL] [Abstract][Full Text] [Related]
35. The contraceptive implant.
Hohmann H; Creinin MD
Clin Obstet Gynecol; 2007 Dec; 50(4):907-17. PubMed ID: 17982333
[TBL] [Abstract][Full Text] [Related]
36. Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study.
Torelli FR; Rodrigues-Peres RM; Monteiro I; Lopes-Cendes I; Bahamondes L; Juliato CRT
Sci Rep; 2024 May; 14(1):11062. PubMed ID: 38745005
[TBL] [Abstract][Full Text] [Related]
37. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
Mark A; Sonalkar S; Borgatta L
Contraception; 2013 Nov; 88(5):619-23. PubMed ID: 23790436
[TBL] [Abstract][Full Text] [Related]
38. Case Report: Traumatic Incomplete Fracture of an Implanon NXT® Contraceptive Implant.
Howett R; Gertz AM; Kgaswanyane T; Petro G; Morroni C
Afr J Reprod Health; 2019 Dec; 23(4):124-128. PubMed ID: 32227747
[TBL] [Abstract][Full Text] [Related]
39. Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels.
Dilbaz B; Ozdegirmenci O; Caliskan E; Dilbaz S; Haberal A
Contraception; 2010 Jun; 81(6):510-4. PubMed ID: 20472118
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
